Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PAVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 6.269M
March 31, 2026 6.269M
December 31, 2025 0.9279M
September 30, 2025 0.7684M
June 30, 2025 0.6714M
March 31, 2025 16.77M
December 31, 2024 0.3733M
September 30, 2024 10.66M
June 30, 2024 9.554M
March 31, 2024 8.859M
December 31, 2023 8.578M
September 30, 2023 7.980M
June 30, 2023 7.236M
March 31, 2023 6.706M
December 31, 2022 6.301M
September 30, 2022 6.149M
June 30, 2022 5.802M
March 31, 2022 0.1931M
December 31, 2021 5.758M
September 30, 2021 5.627M
June 30, 2021 5.505M
March 31, 2021 5.428M
December 31, 2020 4.255M
Date Value
September 30, 2020 3.310M
June 30, 2020 3.195M
March 31, 2020 2.942M
December 31, 2019 2.699M
September 30, 2019 2.437M
June 30, 2019 2.276M
March 31, 2019 1.813M
December 31, 2018 1.810M
September 30, 2018 1.770M
June 30, 2018 1.767M
March 31, 2018 1.167M
December 31, 2017 0.9701M
September 30, 2017 0.8895M
June 30, 2017 0.0296M
March 31, 2017 0.8887M
December 31, 2016 0.8887M
September 30, 2016 0.8873M
June 30, 2016 0.8873M
March 31, 2016 0.8873M
December 31, 2015 0.8873M
September 30, 2015 0.8967M
June 30, 2015 0.8967M
March 31, 2015 0.8967M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 1.730B
AngioDynamics, Inc. 41.70M
Alphatec Holdings, Inc. 152.68M
AtriCure, Inc. 50.86M
Baxter International, Inc. 517.00M